LCs were identified as the main actor in the development of AD-like symptoms in two animal models of AD (MC903-treated mice and K14-TSLP transgenic mice), although both dermal DCs and keratinocytes (KCs) contributed to the inflammatory phenotype. This evidence concerns the gene KRT14 and Alzheimer disease.